Flavanone metabolism in healthy and tumor-bearing rats
M Silberberg1, A Gil-Izquierdo, L Combaret
1Unité des Maladies Métaboliques et Micronutriments, Inra, Centre de Recherche de Clermont-Ferrant/Theix, 63122 Saint-Genès-Champanelle, France. msilber@clermont.inra.fr
Abstract:
Flavanones, the main polyphenols of citrus fruits, are thought to contribute to the protective effects of these fruits against cardiovascular diseases and cancer. The metabolism of naringin (naringenin 7-O-neohesperidoside) is studied here in healthy (sham-operated, ShO) and tumor-bearing (TuB) rats. The tumor was induced by implanting Yoshida's sarcoma in hindlimb. Both groups received for 7 days a semi-synthetic diet containing 0.5% naringin in per feeding conditions. Flavanones were analyzed in plasma, liver, kidney and urine by tandem mass spectrometry. Naringenin conjugates (essentially glucuronides) accounted for up to 98% of the total flavanones in plasma. Low amounts of hesperetin (4'-O-methyl naringénine) and isosakuranetin (3'-hydroxy-4'-O-methylnaringenin) were also detected in all biological samples and accounted for 2% of the total flavanones in plasma. They were largely present as aglycones. The in vivo hydroxylation of flavanones is described here for the first time. Total concentrations of naringenin metabolites reached 17.3+/-2.7 microM in plasma 6 hours after the beginning of the meal in healthy rats and only 10.6+/-1.3 microM in TuB rats. The nature of metabolites was similar in both healthy and TuB rats and in plasma, tissues and urine. The lower concentration of flavanones in the TuB rats suggests that disease and more particularly cancer, may affect the bioavailability of flavonoids.
Insights
Citrus flavanones, like naringin, are metabolized differently in tumor-bearing rats compared to healthy ones. Cancer may reduce the bioavailability of these beneficial plant compounds.
Area of Science:
- Nutritional biochemistry
- Pharmacokinetics
- Cancer research
Background:
- Flavanones, abundant polyphenols in citrus fruits, are linked to protective effects against cardiovascular diseases and cancer.
- Understanding the metabolism and bioavailability of flavanones is crucial for their potential health benefits.
Purpose of the Study:
- To investigate the metabolism of naringin in healthy and tumor-bearing rats.
- To compare the bioavailability of flavanones in different physiological states.
Main Methods:
- Rats (healthy and tumor-bearing) were fed a semi-synthetic diet containing 0.5% naringin for 7 days.
- Flavanone metabolites in plasma, liver, kidney, and urine were analyzed using tandem mass spectrometry.
- In vivo hydroxylation of flavanones was studied.
Main Results:
- Naringenin conjugates (glucuronides) constituted up to 98% of plasma flavanones.
- Hesperetin and isosakuranetin were detected as aglycones, representing 2% of plasma flavanones.
- Total naringenin metabolite concentrations were significantly lower in tumor-bearing rats (10.6 microM) compared to healthy rats (17.3 microM) 6 hours post-meal.
Conclusions:
- The in vivo hydroxylation of flavanones was observed for the first time.
- Metabolite profiles were similar across healthy and tumor-bearing rats, and across different tissues and urine.
- Lower flavanone concentrations in tumor-bearing rats suggest that cancer may impair flavonoid bioavailability.
More Related Videos
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug


